The placebo is commercially available 5% dextrose solution intended for IV, DYNE-251, DYNE-251
DYNE251-DMD-201
Phase 2 small_molecule active
Quick answer
The placebo is commercially available 5% dextrose solution intended for IV, DYNE-251, DYNE-251 for Duchenne muscular dystrophy is a Phase 2 program (small_molecule) at Dyne Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Dyne Therapeutics
- Indication
- Duchenne muscular dystrophy
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active